GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates,

RN-18 is an HIV-1 viral infectivity factor (Vif) inhibitor with IC50 value ranging in 10-30 µM for inhibition of Vif-mediated degradation of the DNA editing enzyme APOBEC3G.

Enfuvirtide is a biomimetic peptide inhibitor of HIV-1 fusion with CD⁴⁺ cells.

L-Buthionine Sulfoximine is a potent inhibitor of GSH synthesis.

ABX-464 is an inhibitor of the HIV replication potentially for the treatment of HIV infection.

Trovirdine inhibits HIV-1 RT with an IC50 of 7 nM when employing heteropolymeric primer/template (oligo-DNA/ribosomal RNA)and dGTP as substrate.

Letrazuril is an antiprotozoal effective against cryptosporidium infections.

BMS-626529 is a small-molecule attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T-cells.

TAK-779 is a highly potent and selective nonpeptide CCR5 antagonist with a IC50 value of 1.4 nM in the binding assay. TAK-779 also inhibits the replication of macrophage (M)-tropic HIV-1 (Ba-L strain) in both MAGI-CCR5 cells and PBMCs with EC50 values of 1.2 and 3.7 nM, respectively.

Cobicistat is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM.

AMD-070 is a potent and selective antagonist of CXCR4 with an IC50 value of 13 nM in a CXCR4 125I-SDF inhibition binding assay, and inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs.

PTACH is a SAHA-based inhibitor of human HDAC. PTACH exerts potent growth inhibition against various human cancer cells, with EC50 values ranging from 1 to 10 μM.

GGsTop (Nahlsgen) is a potent, non-toxic, highly selective and irreversible γ−glutamyl transpeptidase (GGT) inhibitor, with a Ki of 170 μM for Human GGT.